Renal Disease Market Size To Expand at a Notable CAGR Of 11.20% During 2023 - 2030

Pune, India, March, 2023/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Renal Disease Market.

Renal Disease Market Highlights

The global renal disease market is expected to register a CAGR of 11.20% during the forecast period (2023-2030) with a market value of USD 89.07 billion by 2030. 

Renal diseases can be classified as chronic kidney disease (CKD) and end-stage renal disease (ESRD). Renal diseases may cause kidney failure. When CKD worsens, it eventually leads to ESRD. As per the National Institute of Diabetes and Digestive and Kidney Disease Report 2015, more than 6,61,000 Americans had kidney failure.

The rising prevalence of kidney diseases, diabetes, hypertension and rapid growth in the geriatric population have led to the growth of the global renal disease market in recent years. However, rising healthcare costs and stringent regulatory policies are likely to restrain market growth over the forecast period.

Segment analysis

The global renal disease market, by disease type, has been segmented into chronic kidney disease and end-stage renal diseases (ESRD). The chronic kidney disease segment accounted for a value of USD 60,228.68 million in 2017. The market, by treatment type, can be segmented into dialysis, medications and kidney transplantation. On the basis of end user, the global renal disease market is segmented into dialysis centers, hospitals & clinics, and research and academic institutes.

Regional Analysis

The Americas is expected to hold the largest share of the global renal disease market. This is owing to the increasing prevalence of renal diseases in the geriatric population and the availability of advanced healthcare facilities in the region. Europe showed a considerable amount of growth in the market due to high healthcare spending, raising awareness regarding renal diseases, extended recommendations for dialysis by the government and a growing elderly population. Asia-Pacific is estimated to be the fastest growing region in the global market due to the expansion of third-party pharmaceutical companies in China, India, and Singapore. Australia held a share of 11.8% in the Asia-Pacific renal disease market in 2017. Also, the Middle East and Africa region are expected to steadily grow owing to the rising prevalence of renal diseases in the region.

Key Findings of the Study

• The global renal disease market is projected to reach USD 89.07 billion by 2030 at a CAGR of 11.20% during the review period from 2023 to 2030.


• Americas accounted for the largest share of the global market due to the rising prevalence of chronic kidney disease in the region.


• The chronic kidney disease segment accounted for the largest product segment with a revenue of USD 60,228.68 million in 2017.


• Some of the players operating in the renal disease market are Fresenius Medical Care AG & Co. KGaA, AstraZeneca and Keryx Biopharmaceuticals, Inc., among others.

This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global renal disease market, including the high-growth regions and their political, economic, and technological environments. Furthermore, the project report also provides views over historical market values as well as, pricing and cost analysis of the same.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Renal Disease Market Research Report

Related Reports

• Chronic Kidney Disease Market Research Report: By Diagnosis (Blood Test, Urine Test, Biopsy), by Treatment (Drugs, Dialysis, Kidney Transplant), by Indication (Type 1 or Type 2 Diabetes, High Blood Pressure), End-User (Hospitals) - Global Forecast


• Global Renal Dialysis Market Research report, by type (primary dialysis and secondary dialysis), by product (hemodialysis products and peritoneal dialysis products), by end user (hospital care and home care) - Forecast


• Global Kidney Dialysis Equipment Market: By Type (Hemodialysis, Peritoneal Dialysis, Continuous Renal Replacement Therapy), Apparatus Type (Hemodialysis Dialysis Apparatus, Peritoneal Dialysis Apparatus), End-User (Laboratories) –Global Forecast


• Global Renal Cancer Drug Market Research Report, by Therapeutic Class (Targeted Therapy and Immunotherapy), Pharmacologic Class (Angiogenesis Inhibitors), Type (Clear Cell, Papillary, Oncocytic), End-Users (Hospitals & Clinics)–Global Forecast


• Global Kidney Function Test Market Research Report, by Test (Blood Test, Imaging Test, Urine Test), Product (Dipsticks, Disposables, Reagent), End-User (Hospitals & Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers) - Global Forecast